Searched for
TARIFFS ON CANCER MEDICINES
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
Pharmaceutical logistics in demand as war rattles supply chainsMedicines are vital but useless if lost or spoiled. Pharmaceutical logistics ensures their safe delivery. DHL's Florstadt campus near Frank...
Johnson & Johnson to invest $1 billion in new Pennsylvania plant amid US manufacturing pushIn March, the company announced a plan to invest more than $55 billion through early 2029 to build manufacturing facilities and research ...
India Budget 2026: A proposal 'close' to Sitharaman's heart found place in this year's BudgetUnion Budget 2026: Union Finance Minister Nirmala Sitharaman highlighted customs duty exemptions for life-saving medicines in the Union Bud...
Just the booster pill Indian pharma needsIndian Pharma must look at strengthening its presence in established markets in Latin America, China, Russia, Africa and East Europe. This ...
US pharma bets big on China to snap up potential blockbuster drugsU.S. drugmakers are increasingly licensing drug candidates from Chinese biotech firms, with 14 such deals worth up to $18.3 billion signed ...
Trump’s new drug tariffs could hit patients hard - here's a list of essential meds at risk of vanishing fastDonald Trump plans tariffs on pharmaceutical imports, which has led healthcare experts to worry about drug shortages. Common drugs like pai...
Pharma imports to US surged in March as drugmakers look to avoid tariffsU.S. pharmaceutical imports surged in March, exceeding $50 billion, as drugmakers stockpiled inventory in anticipation of potential tariffs...
Could Trump’s proposed pharmaceutical tariffs trigger a drug shortage in the U.S.?On April 8, President Trump announced that his administration would soon implement a “major tariff on pharmaceuticals” imported into the U....
Johnson & Johnson earnings beat estimates on strong cancer drug salesJohnson & Johnson's first-quarter revenue and profit exceeded Wall Street expectations, driven by strong cancer drug sales. The company rai...
Trump tariff threats prompt some drugmakers to expedite shipments to USFearing potential tariffs from President Trump's announcement, some European drugmakers are increasing air shipments of medications to the ...
Trump faces pressure from US industry over China tariff on medicinesU.S. hospitals and generic drugmakers are urging President Trump to exempt medical goods from new tariffs on Chinese imports, warning of po...
China agrees to cut tariffs on Indian cancer drugs: Foreign MinistryIndia has been demanding opening of China's IT and pharmaceutical sectors as part of measures to reduce over USD 51 billion trade deficit i...
China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firmsOn May 4, China said it had removed import duties on as many as 28 medicines, but the need for lengthy trials and approvals has dampened en...
Good news for India's pharma industry: China removes import duties on 28 medicinesChina has exempted import tariffs (duties) for 28 drugs, including all cancer drugs, from May 1st. Good news for India's pharmaceutical ind...